A thyroid hormone analog with reduced dependence on the monocarboxylate transporter 8 for tissue transport

Endocrinology

Volumn 150, Issue 9, 2009, Pages 4450-4458

  Di Cosmo, Caterina ^a   Liao, Xiao Hui ^a   Dumitrescu, Alexandra M ^a   Weiss, Roy E ^a   Refetoff, Samuel ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; DEIODINASE 2; HORMONE RECEPTOR STIMULATING AGENT; IODIDE PEROXIDASE; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LIOTHYRONINE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYROID GLAND;

ANIMALS; BRAIN; DIIODOTHYRONINES; IODIDE PEROXIDASE; LIVER; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; PROPIONIC ACIDS; RECEPTORS, THYROID HORMONE; THYROTROPIN; THYROXINE;

EID: 69249115321     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0209     Document Type: Article

References (39)

1. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128-40135
2. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S 2004 A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74:168-175
3. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP, Visser TJ 2004 Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364:1435-1437
4. Schwartz CE, Stevenson RE 2007 The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. Best Pract Res Clin Endocrinol Metab 21:307-321
5. Refetoff S, Dumitrescu AM 2007 Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab 21:277-305
6. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S 2006 Tissue specific thyroid hormone deprivation and excess in Mct8 deficient mice. Endocrinology 147:4036-4043
7. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K, Heuer H 2007 Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 117:627-635
8. Frints SG, Lenzner S, Bauters M, Jensen LR, Van Esch H, des Portes V, Moog U, Macville MV, van Roozendaal K, Schrander-Stumpel CT, Tzschach A, Marynen P, Fryns JP, Hamel B, van Bokhoven H, Chelly J, Beldjord C, Turner G, Gecz J, Moraine C, Raynaud M, Ropers HH, Froyen G, Kuss AW 2008 MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression. Eur J Hum Genet 16:1029-1037
9. Brockmann K, Dumitrescu AM, Best TT, Hanefeld F, Refetoff S 2005 X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene. J Neurol 252:663-666
10. Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ, Stevenson RE 2005 Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 77:41-53
11. Bernal J 2006 Role of monocarboxylate anion transporter 8 (MCT8) in thyroid hormone transport: answers from mice. Endocrinology 147:4034-4035
12. Wémeau JL, Pigeyre M, Proust-Lemoine E, d'Herbomez M, Gottrand F, Jansen J, Visser TJ, Ladsous M 2008 Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. J Clin Endocrinol Metab 93:2084-2088
13. 4 levels in cerebrospinal fluid. J Pediatr 147:552-554
14. Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N 2008 Expression of the thyroid hormone transporters MCT8 (SLC16A2) and OATP14 (SLCO1C1) at the blood-brain barrier. Endocrinology 149:6251-6261
15. Herzovich V, Vaiani E, Marino R, Dratler G, Lazzati JM, Tilitzky S, Ramirez P, Iorcansky S, Rivarola MA, Belgorosky A 2007 Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene. Horm Res 67:1-6
16. Papadimitriou A, Dumitrescu AM, Papavasiliou A, Fretzayas A, Nicolaidou P, Refetoff S 2008Anovel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay. Pediatrics 121:e199-e202
17. Namba N, Etani Y, Kitaoka T, Nakamoto Y, Nakacho M, Bessho K, Miyoshi Y, Mushiake S, Mohri I, Arai H, Taniike M, Ozono K 2008 Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter. Eur J Pediatr 167:785-791
18. Biebermann H, Ambrugger P, Tarnow P, von Moers A, Schweizer U, Grueters A 2005 Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8. Eur J Endocrinol 153:359-366
19. Pennock GD, Raya TE, Bahl JJ, Goldman S, Morkin E 1992 Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity. J Pharmacol Exp Ther 263:163-169
20. Mousa SA, O'Connor L, Davis FB, Davis PJ 2006 Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology 147:1602-1607
21. Morkin E, Pennock GD, Spooner PH, Bahl JJ, Goldman S 2002 Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid 12:527-533
22. Ladenson PW, McCarren M, Morkin E, Edson R, Warren S, Thai T, O'Brien T, Anand I, Warner A, Dunlap M, Hattler B, Erikson J, Goldman S, Effects of thyromimetic agent 3,5-diiodothyropropionic acid (DITPA) on body weight, BMI, and serum lipoproteins: a prospective randomized, controlled, double-blind VA cooperative study. Program of the 90th Annual Meeting of The Endocrine Society, San Francisco, CA, 2008, p 68 (Abstract S68-2)
23. Hayashi Y, Mangoura D, Refetoff S 1996 A mouse model of resistance to thyroid hormone produced by somatic gene transfer of a mutant thyroid hormone receptor. Mol Endocrinol 10:100-106
24. Weiss RE, Forrest D, Pohlenz J, Cua K, Curran T, Refetoff S 1997 Thyrotropin regulation by thyroid hormone in thyroid hormone receptor β-deficient mice. Endocrinology 138:3624-3629
25. Weiss RE, Murata Y, Cua K, Hayashi Y, Seo H, Refetoff S 1998 Thyroid hormone action on liver, heart and energy expenditure in thyroid hormone receptor β deficient mice. Endocrinology [Erratum (2000) 141:4767] 139:4945-4952
26. Weiss RE, Xu J, Ning G, Pohlenz J, O'Malley BW, Refetoff S 1999 Mice deficient in the steroid receptor coactivator-1 (SRC-1) are resistant to thyroid hormone. EMBO J 18:1900-1904
27. Macchia PE, Takeuchi Y, Kawai T, Cua K, Gauthier K, Chassande O, Seo H, Hayashi Y, Samarut J, Murata Y, Weiss RE, Refetoff S 2001 Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor α. Proc Natl Acad Sci USA 98:349-354
28. 3-regulated transcription of genes in vivo. Endocrinology 143:1346-1352
29. Sadow PM, Chassande O, Gauthier K, Samarut J, Xu J, O'Malley BW, Weiss RE 2003 Specificity of thyroid hormone receptor subtype and steroid receptor coactivator-1 on thyroid hormone action. Am J Physiol Endocrinol Metab 284:E36-E46
30. Pohlenz J, Maqueem A, Cua K, Weiss RE, Van Sande J, Refetoff S 1999 Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid 9:1265-1271
31. Radonić A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A 2004 Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313:856-862
32. Dumitrescu AM, Liao XH, Abdullah MS, Lado-Abeal J, Majed FA, Moeller LC, Boran G, Schomburg L, Weiss RE, Refetoff S 2005 Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 37:1247-1252
33. Balzano S, Bergmann BM, Gilliland MA, Silva JE, Rechtschaffen A, Refetoff S 1990 Effect of total sleep deprivation on 5′-deiodinase activity of rat brown adipose tissue. Endocrinology 127:882-890
34. 3). Endocrinology 150:2491-2496
35. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89
36. Potter GB, Zarach JM, Sisk JM, Thompson CC 2002 The thyroid hormone-regulated corepressor hairless associates with histone deacetylases in neonatal rat brain. Mol Endocrinol 16:2547-2560
37. Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH 2006 Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol Endocrinol 20:2761-2772
38. James SR, Franklyn JA, Reaves BJ, Smith VE, Chan SY, Barrett TG, Kilby MD, McCabe CJ 2009 Monocarboxylate transporter 8 in neuronal cell growth. Endocrinology 150:1961-1969
39. Verhoeven FA, Van der Putten HH, Hennemann G, Lamers JM, Visser TJ, Everts ME 2002 Uptake of triiodothyronine and triiodothyroacetic acid in neonatal rat cardiomyocytes: effects of metabolites and analogs. J Endocrinol 173:247-255